Tim Springer is proud to announce the launch of the Institute for Protein Innovation (IPI). The IPI is designed to foster innovation in protein research and bridge the missing link between genomics and therapeutics. The IPI will advance biomedical research and development in three key ways:
• Stimulate innovative research in protein science by providing critical tools, lead therapeutics, and technologies for academic and industry scientists
• Create an unparalleled environment for training and teaching the next generation of innovators and entrepreneurs in protein science and drug development
• Serve as a cross-institutional and cross-disciplinary organization to forge new ties between academic and industry investigators.
To achieve this mission, the IPI will build and operate an open- source antibody discovery platform, with the long-term goal of developing antibodies targeting the entire human proteome. This resource will enable worldwide advances in research and drug development, driven by the availability of its open-source antibody library.